Exploring the potential transdiagnostic treatment effects of Chinese herbal medicine and acupuncture on insomnia disorder comorbid with chronic pain: A scoping review.

Many adults struggling with insomnia also suffer from chronic pain—a challenging combination that affects over 20% of people with sleep disorders. Standard treatments often fall short: sleep-focused therapies don't consistently relieve pain, while pain medications can worsen insomnia. A new review examined whether traditional Chinese medicine approaches might address both conditions simultaneously.

Researchers analyzed six clinical trials involving 487 adults diagnosed with both insomnia and chronic pain according to standard medical definitions. They looked at studies using Chinese herbal medicine (particularly modified Guipi decoction and Da Huoluo capsules) and acupuncture treatments.

The findings were encouraging. Chinese herbal formulas showed medium to large improvements in both sleep quality and pain levels compared to conventional sleeping medications like diazepam. Acupuncture also demonstrated medium to large benefits for both insomnia and pain when compared to usual care. When herbal medicine and acupuncture were combined, patients still experienced meaningful improvements in both conditions.

What this means: If you're dealing with both chronic pain and insomnia, acupuncture and Chinese herbal medicine may offer a treatment approach that addresses both problems together, rather than treating them separately with medications that might interfere with each other. However, researchers noted that most studies had methodological limitations, meaning more high-quality research is needed to confirm these promising results.

Before pursuing these treatments, consult with a licensed acupuncturist or qualified traditional Chinese medicine practitioner who can evaluate your specific situation and create an appropriate treatment plan.

This scoping review evaluated Chinese herbal medicine (CHM) and acupuncture for insomnia disorder comorbid with chronic pain (ICCP), analyzing six RCTs with 487 participants meeting DSM-5 insomnia and IASP chronic pain criteria. Modified Guipi decoction demonstrated medium to large effect sizes for insomnia (d=0.70-1.17) and pain (d=0.67-1.42) versus benzodiazepines. Acupuncture showed comparable efficacy with medium to large effects for insomnia (d=0.64-0.99) and pain (d=0.80-1.33) compared to treatment as usual. Combined CHM (Da Huoluo capsules) and acupuncture produced medium effects (d=0.72 for insomnia; d=0.57 for pain) versus multi-medication approaches. Effect sizes were calculated using modified Cohen's d, and bias was assessed via Cochrane RoB 2 tool, revealing 83.33% of studies had high risk of bias. Clinical takeaway: CHM and acupuncture show transdiagnostic potential for ICCP management, but methodological limitations necessitate cautious interpretation pending higher-quality trials.